157 related articles for article (PubMed ID: 22145958)
1. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
[TBL] [Abstract][Full Text] [Related]
2. miR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemia.
Zhou K; Yu Z; Yi S; Li Z; An G; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2014 Jul; 55(7):1544-50. PubMed ID: 24138306
[TBL] [Abstract][Full Text] [Related]
3. [Expression of microRNA-223 and its clinical value in B lymphoproliferative disorders].
Zhou KS; Yu Z; Yi SH; Li ZJ; An G; Wang YY; Zou DH; Qi JY; Zhao YZ; Song YP; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 Sep; 91(34):2384-7. PubMed ID: 22321781
[TBL] [Abstract][Full Text] [Related]
4. [The expression of microRNA-155 and microRNA-146a and its' clinical value in chronic lymphoproliferative disorders].
Zhou KS; Yu Z; Yi SH; Li ZJ; Li YF; An G; Zou DH; Qi JY; Zhao YZ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):656-9. PubMed ID: 22339821
[TBL] [Abstract][Full Text] [Related]
5. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
[TBL] [Abstract][Full Text] [Related]
7. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.
Papageorgiou SG; Kontos CK; Tsiakanikas P; Stavroulaki G; Bouchla A; Vasilatou D; Bazani E; Lazarakou A; Scorilas A; Pappa V
Leuk Res; 2018 Jul; 70():1-7. PubMed ID: 29715621
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia.
Papageorgiou SG; Diamantopoulos MA; Kontos CK; Bouchla A; Vasilatou D; Bazani E; Scorilas A; Pappa V
Leuk Lymphoma; 2019 Mar; 60(3):658-667. PubMed ID: 29911923
[TBL] [Abstract][Full Text] [Related]
9. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
10. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.
Papageorgiou SG; Kontos CK; Diamantopoulos MA; Bouchla A; Glezou E; Bazani E; Pappa V; Scorilas A
Dis Markers; 2017; 2017():2046545. PubMed ID: 29463948
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
[TBL] [Abstract][Full Text] [Related]
13. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.
Chen L; Zhang Y; Zheng W; Wu Y; Qiao C; Fan L; Xu W; Li J
Leuk Res; 2008 Oct; 32(10):1491-8. PubMed ID: 18359082
[TBL] [Abstract][Full Text] [Related]
14. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
15. NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.
Yang YQ; Tian T; Zhu HY; Liang JH; Wu W; Wu JZ; Xia Y; Wang L; Fan L; Li JY; Xu W
BMC Cancer; 2018 Oct; 18(1):1009. PubMed ID: 30348117
[TBL] [Abstract][Full Text] [Related]
16. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms.
El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344
[TBL] [Abstract][Full Text] [Related]
17. MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.
Visone R; Veronese A; Balatti V; Croce CM
Oncotarget; 2012 Feb; 3(2):195-202. PubMed ID: 22350310
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
19. Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
Visone R; Rassenti LZ; Veronese A; Taccioli C; Costinean S; Aguda BD; Volinia S; Ferracin M; Palatini J; Balatti V; Alder H; Negrini M; Kipps TJ; Croce CM
Blood; 2009 Oct; 114(18):3872-9. PubMed ID: 19717645
[TBL] [Abstract][Full Text] [Related]
20. High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.
Butrym A; Majewski M; Dzietczenia J; Kuliczkowski K; Mazur G
Leuk Res; 2012 Jul; 36(7):876-80. PubMed ID: 22333038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
